
Loading, please wait...

Loading, please wait...

This pilot trial evaluated the safety and efficacy of low-intensity focused ultrasound (LIFU) targeting the seizure onset zone in 12 patients with drug-resistant epilepsy. During the randomized crossover phase, LIFU did not significantly reduce seizure frequency compared with sham stimulation (estimate 0.49; 95% CI −0.04 to 1.01; P=.068). However, during open-label follow-up, seizure frequency declined significantly by 14.0 percentage points per month (95% CI −22.2 to −5.8; P=.001). MRI showed no structural lesions, and no serious adverse events occurred. Anxiety, depression, and quality-of-life scores did not significantly change. The authors note that larger, longer parallel-group trials are needed to establish efficacy.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


This pilot trial evaluated the safety and efficacy of low-intensity focused ultrasound (LIFU) targeting the seizure onset zone in 12 patients with drug-resistant epilepsy. During the randomized crossover phase, LIFU did not significantly reduce seizure frequency compared with sham stimulation (estimate 0.49; 95% CI −0.04 to 1.01; P=.068). However, during open-label follow-up, seizure frequency declined significantly by 14.0 percentage points per month (95% CI −22.2 to −5.8; P=.001). MRI showed no structural lesions, and no serious adverse events occurred. Anxiety, depression, and quality-of-life scores did not significantly change. The authors note that larger, longer parallel-group trials are needed to establish efficacy.
2 months ago

Researchers have identified compound 8g, an orally bioavailable corydamine derivative that targets glutathione reductase. By dismantling redox defenses and disrupting NADPH homeostasis, 8g acts synergistically with sorafenib to trigger apoptosis and overcome drug resistance in hepatocellular carcinoma models.
Yesterday

A breakthrough blood test measuring the RNA biomarker Tu-Stroma detects microscopic serous tubal intraepithelial carcinoma (STIC) lesions with remarkable accuracy. This non-invasive diagnostic tool offers crucial biological insight to guide prophylactic surgery decisions for women carrying high-risk genetic mutations.
2 days back

Researchers have engineered novel light-on photoswitchable adrenoceptor agonists targeting β1-receptors. By remaining inactive until illuminated, these precision molecules offer reversible optical control, tailored relaxation kinetics, and distinct efficacy profiles, paving the way for targeted cardiovascular therapies.
Yesterday

A single-cell transcriptomic atlas reveals how peripheral nerve injuries cause dorsal root ganglion remodeling. By evaluating proximal nerve crush and resection, researchers identify distinct glial and immune programs that resolve neuropathic pain and promote regeneration.
3 weeks back

A breakthrough study demonstrates that fullerol-primed extracellular vesicles generated in a 3D SECCS bioreactor attenuate ferroptosis and restore myogenic regeneration in diabetes via the FOXO3 pathway, offering a cell-free therapeutic strategy for diabetic musculoskeletal degeneration.
3 weeks back